Categories AlphaGraphs, Consumer, Earnings

Infographic: The JM Smucker Company Q1 2021 earnings

JM Smucker Company (NYSE: SJM) reported second-quarter financial results before the opening bell on Tuesday. The company reported an 11% increase in Q2 net sales to $1.97 billion, beating Wall Street consensus. Net earnings of $2.08 per share also handsomely surpassed what analysts had anticipated.

SJM shares rose 3.3% immediately following the announcement. The stock has increased 11% so far this year.

JM Smucker Company Q1 2021 earnings

Looking forward to listening to management/ analyst comments on Q2 results? Stay tuned here for JM Smucker Q2 2020 earnings call transcript

CEO Mark Smucker said, “We expect continued momentum in the second quarter and are pleased to raise our full-year guidance. We remain confident in our ability to deliver on our fiscal year 2021 goals, advance our long-term strategy, and deliver increased shareholder value.”

Prior performance

Most Popular

Agentforce in focus as Salesforce (CRM) gets ready for Q3 2025 earnings

After delivering mixed results in the first half, Salesforce, Inc. (NYSE: CRM) looks poised to report strong numbers when it publishes third-quarter results next week. The Customer relationship management platform

What to look for when Dollar Tree (DLTR) reports Q3 2024 earnings

Shares of Dollar Tree, Inc. (NASDAQ: DLTR) rose over 5% on Monday. The stock has dropped 27% over the past three months. The discount store chain is scheduled to report

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top